WHO Drug Information Vol. 14, No. 1, 2000
(2000; 81 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoGeneral Policy Issues
Abrir esta carpeta y ver su contenidoPersonal Perspectives
Abrir esta carpeta y ver su contenidoReports on Individual Drugs
Abrir esta carpeta y ver su contenidoCurrent Topics
Abrir esta carpeta y ver su contenidoVaccines and Biomedicines
Abrir esta carpeta y ver su contenidoGeneral Information
Cerrar esta carpetaRegulatory and Safety Matters
Ver el documentoTroglitazone withdrawn
Ver el documentoCisapride and cardiac effects
Ver el documentoCisapride: changes to labelling
Ver el documentoCisapride: updated warning issued
Ver el documentoSt John's wort: recommendations for use
Ver el documentoNorthern hemisphere influenza vaccine
Ver el documentoNicotine replacement therapy
Ver el documentoAnorectic agents: suspension of marketing authorization
Ver el documentoInsulin cartridges: leakage risk
Ver el documentoZimox®: trade name duplication and risk of errors
Ver el documentoBenzbromarone and hepatitis
Ver el documentoNevirapine: severe cutaneous reactions
Ver el documentoFDA cannot regulate tobacco industry
Ver el documentoNew Internet website: information for consumers
Ver el documentoCyber warnings for drug sales via the Internet
Ver el documentoTriax®: a harmful product sold on the Internet
Ver el documentoIllegal products on the market
Ver el documentoEpoetin alfa: inappropriate practices compromise product sterility
Ver el documentoPropylene glycol and amprenavir
Ver el documentoTrastuzumab: pulmonary reactions
Abrir esta carpeta y ver su contenidoATC/DDD Classification
Abrir esta carpeta y ver su contenidoRecent Publications and Documents
Abrir esta carpeta y ver su contenidoInternational Nonproprietary Names for Pharmaceutical Substances (INN)
Ver el documentoSelected WHO Publications of Related Interest
 

Cyber warnings for drug sales via the Internet

United States of America - In recent weeks the Food and Drug Administration has issued letters via the Internet to operators of non USA-based internet sites that offer to sell on-line prescription medicines that may be illegal. The letters inform the operators about the laws governing prescription drug sales within the USA, with an explanation of the statutory provisions that govern interstate commerce of drugs and a warning that future shipments of the products may be automatically detained and subject to refusal of entry.

Reference: FDA Talk Paper, T00-8 (2000).

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013